OTC Medicines

CHPA echoed concerns in a letter sent to the U.S. Food and Drug Administration by U.S. Reps. Bob Latta (OH-05), Debbie Dingell (MI-06), and Dan Crenshaw (TX-02), urging the Agency to ensure the simultaneous marketing provision of its proposed rule for Nonprescription Drug Product With an Additional Condition for Nonprescription Use is not included in a final rule.

The Consumer Healthcare Products Association Educational Foundation today released the following statement announcing the 2023 U.S. Self-Care Marketing Awards finalists. Winners will be announced at the Eighth Annual CHPA Educational Foundation Gala on November 15 at The Bellevue Hotel in Philadelphia. Specific awards will recognize the strategic innovation and marketing expertise of CHPA member companies in the OTC medicine, consumer medical device, and dietary supplement industries.

In recent years, policies in European countries have been a growing source of inspiration for similar laws passed in individual U.S. states. States have progressively looked to Europe for policy guidance on matters like making producers responsible for packaging waste, pharmaceutical drug disposal, chemical restrictions, and more.

A recent national survey of adults conducted by the Bullfinch Group for CHPA further sheds light on consumer awareness, experiences, and perceptions of PE.

The Consumer Healthcare Products Association (CHPA) Educational Foundation and Family Dollar today announced the launch of a program to help Family Dollar shoppers make informed, educated choices about choosing and using over-the-counter (OTC) products and dietary supplements.

Bill proposes to make dietary supplements eligible expenses in FSA/HSA accounts, allowing consumers to use tax-preferred health savings to purchase wellness products.

Consumer Healthcare Products Association (CHPA) President and CEO Scott Melville today released the below statement following the U.S. Food and Drug Administration (FDA) approving Opill®